Dermatitis therapeutics Pipeline Review, H2 2015 - Research and Markets
February 08 2016 - 12:37PM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/3fb8ql/dermatitis) has
announced the addition of the "Dermatitis - Pipeline Review, H2
2015" report to their offering.
This report provides comprehensive information on the
therapeutic development for Dermatitis, complete with comparative
analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and
molecule type, along with latest updates, and featured news and
press releases. It also reviews key players involved in the
therapeutic development for Dermatitis and special features on
late-stage and discontinued projects.
The report enhances decision making capabilities and help to
create effective counter strategies to gain competitive advantage.
It strengthens R&D pipelines by identifying new targets and
MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Dermatitis Overview
- Therapeutics Development
- Pipeline Products for Dermatitis - Overview
- Pipeline Products for Dermatitis - Comparative Analysis
- Dermatitis - Therapeutics under Development by Companies
- Dermatitis - Therapeutics under Investigation by
Universities/Institutes
- Dermatitis - Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Dermatitis - Products under Development by Companies
- Dermatitis - Products under Investigation by
Universities/Institutes
- Dermatitis - Companies Involved in Therapeutics
Development
Companies Mentioned - Sample List
- 3SBio Inc.
- Abeome Corporation
- Accolade Pharma LLC
- Aclaris Therapeutics, Inc.
- China Biologic Products, Inc.
- ChironWells GmbH
- Chugai Pharmaceutical Co., Ltd.
- Convoy Therapeutics, Inc.
- Creabilis SA
- Delenex Therapeutics AG
- Dermira Inc.
- Dr. August Wolff GmbH & Co. KG Arzneimittle
- Eisai Co., Ltd.
- Eli Lilly and Company
- EpiPharm AG
- F. Hoffmann-La Roche Ltd.
- FAES Farma SA
- Foamix Pharmaceuticals Ltd.
- Ziarco Pharma Ltd
For more information visit
http://www.researchandmarkets.com/research/3fb8ql/dermatitis
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160208006140/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Immune Disorders